KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Short term Debt (2018 - 2021)

Twist Bioscience (TWST) has disclosed Short term Debt for 4 consecutive years, with $9.1 million as the latest value for Q4 2021.

  • Quarterly Short term Debt rose 172.49% to $9.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2021, up 172.49% year-over-year, with the annual reading at $1.6 million for FY2021, 53.44% down from the prior year.
  • Short term Debt for Q4 2021 was $9.1 million at Twist Bioscience, up from $1.6 million in the prior quarter.
  • The five-year high for Short term Debt was $9.1 million in Q4 2021, with the low at $1.6 million in Q3 2021.
  • Average Short term Debt over 4 years is $3.5 million, with a median of $3.3 million recorded in 2018.
  • Peak annual rise in Short term Debt hit 172.49% in 2021, while the deepest fall reached 53.44% in 2021.
  • Over 4 years, Short term Debt stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then soared by 172.49% to $9.1 million in 2021.
  • According to Business Quant data, Short term Debt over the past three periods came in at $9.1 million, $1.6 million, and $2.4 million for Q4 2021, Q3 2021, and Q2 2021 respectively.